AnalystsMartin FanMartin Fan's Stock Forecasts
AnalystsMartin Fan
Sectors:
Industries:
Analyst Ranking
Top 19%
#968 out of 5208 analysts
Average Return
+46.24%
Win Rate
71%12 out of 17
Risk vs Reward
Poor
Good
Martin Fan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | +247.15% | $9.46 | $32.84 | 2025-05-14 - 2026-03-03 | Buy |
Anaptysbio IncANAB | +159.35% | $20.37 | $52.83 | 2025-08-06 - 2026-03-03 | Buy |
Anaptysbio IncANAB | +143.46% | $21.70 | $52.83 | 2025-04-30 - 2026-03-03 | Buy |
Aclaris Therapeutics IncACRS | +115.60% | $1.41 | $3.04 | 2025-05-27 - 2026-03-03 | Buy |
Anaptysbio IncANAB | +72.53% | $30.62 | $52.83 | 2025-09-29 - 2026-03-03 | Buy |
Martin Fan Analyst Color
Get additional color on Martin Fan's coverage of popular stocks
Martin Fan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zura Bio LtdZURA | 1 | Buy | $15.00 | +131.12% | Initiates Coverage On | 23 days ago |
Oruka Therapeutics IncORKA | 2 | Buy | $45.00 | +37.03% | Maintains | 2 months ago |
Zenas Biopharma IncZBIO | 2 | Buy | $45.00 | +78.71% | Reiterates | 2 months ago |
Vor Biopharma IncVOR | 1 | Hold | $9.00 | -39.80% | Assumes | 3 months ago |
Imagenebio IncIMA | 1 | Sell | $2.00 | -67.27% | Assumes | 3 months ago |
Anaptysbio IncANAB | 5 | Buy | $50.00 | -5.36% | Reiterates | 3 months ago |
Sana Biotechnology IncSANA | 2 | Buy | $6.00 | +52.67% | Maintains | 4 months ago |
Artiva Biotherapeutics IncARTV | 2 | Buy | $23.00 | +320.48% | Maintains | 5 months ago |
Cartesian Therapeutics IncRNAC | 1 | Buy | $38.00 | +408.02% | Initiates Coverage On | 8 months ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $8.00 | +163.16% | Initiates Coverage On | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.